Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice

D. Bedoret, H. Wallemacq, T. Marichal, C. Desmet, F.Q. Calvo, E. Henry, R. Closset, B. Dewals, C. Thielen, P. Gustin, L. de Leval, N. van Rooijen, A. Le Moine, A. Vanderplasschen, D. Cataldo, P.V. Drion, M.B. Moser, P. Lekeux, F. Bureau

Research output: Contribution to journalArticleAcademicpeer-review

164 Downloads (Pure)


The respiratory tract is continuously exposed to both innocuous airborne antigens and immunostimulatory molecules of microbial origin, such as LPS. At low concentrations, airborne LPS can induce a lung DC-driven Th2 cell response to harmless inhaled antigens, thereby promoting allergic asthma. However, only a small fraction of people exposed to environmental LIPS develop allergic asthma. What prevents most people from mounting a lung DC-driven Th2 response upon exposure to LPS is not understood. Here we have shown that lung interstitial macrophages (IMs), a cell population with no previously described in vivo function, prevent induction of a Th2 response in mice challenged with LPS and an experimental harmless airborne antigen. IMs, but not alveolar macrophages, were found to produce high levels of IL-10 and to inhibit LPS-induced maturation and migration of DCs loaded with the experimental harmless airborne antigen in an IL-10-dependent manner. We further demonstrated that specific in vivo elimination of IMs led to overt asthmatic reactions to innocuous airborne antigens inhaled with low doses of LPS. This study has revealed a crucial role for IMs in maintaining immune homeostasis in the respiratory tract and provides an explanation for the paradox that although airborne LPS has the ability to promote the induction of Th2 responses by lung DCs, it does not provoke airway allergy under normal conditions
Original languageEnglish
Pages (from-to)3723-3738
Number of pages16
JournalJournal of Clinical Investigation
Issue number12
Publication statusPublished - 2009

Cite this